| AVTX Stock | | | USD 10.13 0.48 4.97% |
Avalo Therapeutics financial indicator trend analysis is way more than just evaluating Avalo Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avalo Therapeutics is a good investment. Please check the relationship between Avalo Therapeutics Non Current Assets Total and its Accounts Payable accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Avalo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Avalo Stock please use our
How to Invest in Avalo Therapeutics guide.
Non Current Assets Total vs Accounts Payable
Non Current Assets Total vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Avalo Therapeutics Non Current Assets Total account and
Accounts Payable. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Avalo Therapeutics' Non Current Assets Total and Accounts Payable is 0.19. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Avalo Therapeutics, assuming nothing else is changed. The correlation between historical values of Avalo Therapeutics' Non Current Assets Total and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Avalo Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Non Current Assets Total i.e., Avalo Therapeutics' Non Current Assets Total and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.19 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Accounts Payable
An accounting item on the balance sheet that represents Avalo Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Avalo Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Avalo Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avalo Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Avalo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Avalo Stock please use our
How to Invest in Avalo Therapeutics guide.At this time, Avalo Therapeutics'
Selling General Administrative is fairly stable compared to the past year.
Tax Provision is likely to rise to about 32.5
K in 2024, whereas
Discontinued Operations is likely to drop (32.6
K) in 2024.
Avalo Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Avalo Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avalo Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Avalo Stock Analysis
When running Avalo Therapeutics' price analysis, check to
measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.